Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.
Jahromi, Amin Haghighat
Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1. [electronic resource] - Journal of medicinal chemistry Dec 2013 - 9471-9481 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1520-4804
10.1021/jm400794z doi
Humans
Ligands
Microscopy, Confocal
Myotonic Dystrophy--genetics
Polyamines--chemical synthesis
RNA--genetics
RNA-Binding Proteins--antagonists & inhibitors
Thermodynamics
Trinucleotide Repeats
Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1. [electronic resource] - Journal of medicinal chemistry Dec 2013 - 9471-9481 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1520-4804
10.1021/jm400794z doi
Humans
Ligands
Microscopy, Confocal
Myotonic Dystrophy--genetics
Polyamines--chemical synthesis
RNA--genetics
RNA-Binding Proteins--antagonists & inhibitors
Thermodynamics
Trinucleotide Repeats